MedPath
HSA Approval

DCLOT 5 FILM COATED TABLETS 5 MG

SIN16674P

DCLOT 5 FILM COATED TABLETS 5 MG

DCLOT 5 FILM COATED TABLETS 5 MG

January 11, 2023

NATCO PHARMA ASIA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNATCO PHARMA ASIA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

B01AF02

apixaban

Manufacturer Information

NATCO PHARMA ASIA PTE. LTD.

Natco Pharma Limited

Active Ingredients

Apixaban

5mg

Apixaban

Documents

Package Inserts

Dclot Tablet PI.pdf

Approved: January 11, 2023

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DCLOT 5 FILM COATED TABLETS 5 MG - HSA Approval | MedPath